Iron deficiency, platelets and thromboembolism in cancer patients

• Conditions: colorectal cancer, iron deficiency; MedDRA version: 16.0Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps); MedDRA version: 16.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disorders; Therapeutic area: Diseases [C] - Cancer [C04]

• Registration Number: EUCTR2012-002981-11-AT
• Lead Sponsor: Medizinische Universität Wien, Klinik für Innere Medizin III, Abteilung für Gastroenterologie und Hepatologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-09-09
• Last Update Posted: 7 October 2013

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

newly diagnosed colorectal cancer
iron deficiency
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 84
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

hemoglobin<9g/dL
ongoing chemotherapy
therapy which influences platelets
blood transfusion or iron therapy within 30 days befor study entry

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified